Insider Transactions in Q4 2023 at Igm Biosciences, Inc. (IGMS)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2023
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
492
+0.02%
|
-
|
|
Dec 29
2023
|
Michael Stewart Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
492
+10.67%
|
-
|
|
Dec 29
2023
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
800
+10.3%
|
-
|
|
Dec 29
2023
|
Christina Teng Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
738
+1.77%
|
-
|
|
Dec 29
2023
|
Jakob Haldor Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
492
+0.59%
|
-
|
|
Dec 29
2023
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
1,108
+0.1%
|
-
|
|
Dec 15
2023
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
288,007
+2.35%
|
$1,728,042
$6.44 P/Share
|
|
Dec 14
2023
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
157,370
+4.14%
|
$944,220
$6.5 P/Share
|
|
Dec 13
2023
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
7,574
-5.52%
|
$37,870
$5.78 P/Share
|
|
Dec 13
2023
|
Fred Schwarzer CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
17,576
-14.6%
|
$87,880
$5.78 P/Share
|
|
Dec 13
2023
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
4,369
-10.92%
|
$21,845
$5.78 P/Share
|
|
Dec 13
2023
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
87,316
+1.23%
|
$436,580
$5.88 P/Share
|
|
Nov 29
2023
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
1,180
-2.87%
|
$7,080
$6.21 P/Share
|
|
Nov 29
2023
|
George Gauthier Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,180
-2.89%
|
$7,080
$6.21 P/Share
|
|
Nov 29
2023
|
Chris H Takimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,180
-2.16%
|
$7,080
$6.21 P/Share
|
|
Nov 27
2023
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,337
-2.62%
|
$6,685
$5.06 P/Share
|
|
Nov 27
2023
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
933
-0.68%
|
$4,665
$5.06 P/Share
|
|
Nov 27
2023
|
Fred Schwarzer CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
1,337
-1.1%
|
$6,685
$5.06 P/Share
|
|
Nov 15
2023
|
George Gauthier Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,740
+4.09%
|
$8,700
$5.02 P/Share
|
|
Nov 15
2023
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
234
+0.46%
|
$2,574
$11.71 P/Share
|
|
Oct 02
2023
|
George Gauthier Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
935
-2.34%
|
$6,545
$7.95 P/Share
|